Xcout IntelHARROW HEALTH, INC.
Harrow Health, Inc. is a specialty pharmaceutical company focused on ophthalmic products, including FDA-approved and compounded medications used in eye care. It serves ophthalmologists, other eye-care professionals, and patients requiring treatments for conditions and procedures involving the eye.
Subscribe to see HARROW HEALTH, INC.’s full profile → the full roster, investors in every round, weekly hiring history and every corporate event
HARROW HEALTH, INC. at a glance
HARROW HEALTH, INC. is a pharmaceuticals company headquartered in United States. Its most recent funding round raised $10.7M in May 2021. Xcout recorded 57 job postings from HARROW HEALTH, INC. in the last 90 days, naming tools such as Salesforce, Pardot, Tableau.
HARROW HEALTH, INC. funding rounds
Every round on record:
| Date | Round | Amount | Investors |
|---|---|---|---|
| SEC Form D filing | $10.7M | — |
Who invested in each round, lead investors, valuations and the co-investor graph — open the full funding history →
Hiring at HARROW HEALTH, INC.
Xcout recorded 57 job postings from HARROW HEALTH, INC. in the last 90 days, from a hiring record Xcout has kept since July 2026.
Tools named in HARROW HEALTH, INC.'s job postings
The weekly hiring trend, the roles and locations behind it — see HARROW HEALTH, INC.'s hiring signals →
Hiring vs the trend
Based on 24 job postings in the last 8 weeks (17 Aug – 11 Oct 2026), compared with 181 scale-up healthcare companies.
This describes a hiring pattern — how often HARROW HEALTH, INC.’s job postings ask for AI skills, and how that changed against the previous 8 weeks, ranked among its peers. It says nothing about the company’s products or performance.
Signed-in members see the AI-skill share and its change with peer percentiles, role mix, posting momentum and advertised US pay against the market.
HARROW HEALTH, INC. competitors
A few of HARROW HEALTH, INC.'s closest competitors — see the full list of competitors and alternatives →
Harrow is a Nashville, Tennessee-based pharmaceutical provider that entered into an agreement to acquire the Tyrvaya dry eye treatment from Viatris Inc.
CMP Pharma is a specialty pharmaceutical company that develops and manufactures high-value branded and generic oral liquids, semi-solid topical products, and non-prescription pharmaceuticals. The company serves hospitals, long-term care facilities, and retail channels to provide customized care and alternative formulations for patient populations with unmet needs, such as those with difficulty swallowing.
Bausch Health Companies Inc., together with its associated entities, is engaged in the development, manufacturing, and commercialization of a diverse portfolio of pharmaceutical products, medical devices, and over-the-counter remedies. Its primary therapeutic focus areas include ophthalmology, digestive health, and dermatology. The enterprise conducts its operations through five principal divisions: Bausch + Lomb, Salix, International Rx, Ortho Dermatologics, and Diversified Products. The Bausch + Lomb segment is dedicated to vision care, encompassing surgical instruments, consumer eye health products, and ophthalmic pharmaceuticals. Salix specializes in delivering gastroenterology-specific products exclusively within the United States. The International Rx division markets Solta products, a range of branded and generic pharmaceuticals, OTC items, medical devices, and Bausch + Lomb offerings across diverse geographies including Canada, Europe, Asia, Australia, Latin America, Africa, and the Middle East. Ortho Dermatologics focuses on dermatological products in the U.S., in addition to distributing Solta's medical aesthetic devices globally. Finally, the Diversified Products segment supplies pharmaceutical solutions for neurology and other therapeutic categories, as well as generic medications and dental products, all within the U.S. The company was formerly known as Valeant Pharmaceuticals International, Inc., officially changing its name to Bausch Health Companies Inc. in July 2018. Its corporate headquarters are located in Laval, Canada.
Akorn, Inc. is a pharmaceutical company with its main headquarters located in Lake Forest, Illinois, alongside various manufacturing and operational facilities.
JAMP Pharma Group is a private Canadian pharmaceutical company launched in 1988 and based in the Montreal region of Quebec. Originally operating as a contract manufacturing organization, the company now actively supplies a broad range of pharmaceutical products across Canada.
SK-Pharma is a global pharmaceutical company and supplier of medications, specializing in early generics, rare drugs, value-added generics, and specialty products such as orphan drugs and complex generics. The company focuses on improving drug accessibility, market monitoring, and supply chain optimization to serve patients worldwide.
Get HARROW HEALTH, INC.'s news by email
Funding rounds, acquisitions, new executives, launches and expansions, each with a two-line summary and a link to the source. One short email a day, only when there is news.
Free: up to 5 companies, daily. Subscribers also follow whole sectors and saved filters (M&A in Israel, AI funding…), get instant alerts, in-app notifications and signed webhooks, and open the full profile behind every name. Subscribe →
Share this card
Post the link and the card appears automatically — each network fetches the image itself.
More on HARROW HEALTH, INC. in Xcout Intel
- 1 funding round with the investors in each, and who they co-invest with
- Weekly hiring history and the mix of roles behind it
- 2 corporate events with sources — deals, leadership changes, layoffs
- The full competitor set, tracking, exports and API access